# Efficacy of Botulinum Toxin Type A for the Treatment of Non-neurogenic Urinary Urge Incontinence

> **NCT01226706** · NA · COMPLETED · sponsor: **Saskatchewan Health Authority - Regina Area** · enrollment: 21 (actual)

## Conditions studied

- Urinary Urge Incontinence

## Interventions

- **DRUG:** Botulinum Toxins, Type A
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT01226706
- **Lead sponsor:** Saskatchewan Health Authority - Regina Area
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-09
- **Final completion:** 2012-10
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01226706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01226706, "Efficacy of Botulinum Toxin Type A for the Treatment of Non-neurogenic Urinary Urge Incontinence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01226706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*